Schedule 13G ownership disclosure

CONTRAVIR PHARMA

Security class unavailable · CUSIP: 21234W103

Event date: 2019-03-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,411,750
Percent of class
16.5700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-019188
Form type
SC 13G
Filer
Hepion Pharmaceuticals, Inc.
CIK
CIK 1583771
Filed
Apr 02, 2019
Reporting period
Mar 13, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub